MSB 4.07% $1.15 mesoblast limited

CLBP Trial 2024, page-13

  1. 3,804 Posts.
    lightbulb Created with Sketch. 359
    Two years to determine any adverse events and Secondary Outcome relating to Opioid Usage (24 months). 12 months and a bit for low back pain results.

    Primary Completion 24 months.
    Primary Outcome Measures
    1. Mean Change From Baseline in Daily Average Low Back Pain at 12 Months Post-treatment Based on Visual Analog Scale (VAS) Score
      Low back pain intensity will be measured using a VAS ranging from 0-100 millimeter (mm). A score of 0 represents no pain and 100 represents worst possible pain.
      [Time Frame: Baseline and Month 12]
    2. Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs)
      [Time Frame: Up to Month 24]


    Last edited by vasilios: Today, 09:45
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.15
Change
0.045(4.07%)
Mkt cap ! $1.313B
Open High Low Value Volume
$1.08 $1.16 $1.08 $4.681M 4.170M

Buyers (Bids)

No. Vol. Price($)
1 99680 $1.15
 

Sellers (Offers)

Price($) Vol. No.
$1.16 31000 2
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.